Lung function measurement

OTHER5 trials

Sponsors

University of Zurich, Johann Wolfgang Goethe University Hospital, Haukeland University Hospital, University of Southampton

Conditions

Ataxia TelangiectasiaFabry DiseaseImmunodeficiencyInfectionsInflammatory MyositisLung DiseasePrimary Ciliary DyskinesiaRheumatoid Arthritis

Unknown Phase

Rituximab-induced Pulmonary Function Changes

University of ZurichInflammatory Myositis, Rheumatoid Arthritis

Start: 2012-01-31End: 2013-12-31Target: 80Updated: 2012-06-29

Pulmonary Involvement in Patients With Fabry Disease

CompletedNCT01632111

University of ZurichFabry Disease

Start: 2012-07-31End: 2014-05-31Updated: 2014-05-28

Susceptibility to Infections in Ataxia Telangiectasia

CompletedNCT02345135

Johann Wolfgang Goethe University HospitalAtaxia Telangiectasia, Immunodeficiency, Infections +1

Start: 2012-09-30End: 2016-07-31Updated: 2017-11-30

A Clinical Study Aiming to Validate the Equipment: VoluSense Pediatrics (VSP)

Haukeland University HospitalLung Disease

Start: 2015-12-31End: 2016-03-31Target: 50Updated: 2016-03-04

PRospective Observational Multicentre Study on VAriability of Lung Function in Stable PCD Patients

University of SouthamptonPrimary Ciliary Dyskinesia

Start: 2017-08-23End: 2019-12-31Updated: 2018-10-15

Related Papers

Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-Telangiectasia.

2021-09-0318 citations